Perimenopause and Menopause: An Honest Companion to the Change

Most women arrive at perimenopause knowing two things: hot flushes exist, and periods eventually stop. Almost nothing else has been explained to them. What follows is drawn from the accounts of women who have been through it, alongside the current NICE guideline for the UK. It is companion reading, not medical advice, and treatment decisions belong between you and a clinician who knows your history.

Perimenopause is the part nobody named

The single most repeated frustration in these accounts is that the difficult years came before anything obvious stopped. Perimenopause is the transitional phase leading up to the final period, and it commonly runs for four to eight years, sometimes longer. Periods may become heavier, lighter, closer together, further apart, or wildly unpredictable, and all of that can happen while a woman is still menstruating regularly enough to assume nothing is going on.

Because the framing in public conversation is "menopause equals hot flushes at fifty", women in their early forties describe not connecting any of it. The accounts are full of women who went to a GP about anxiety, or joint pain, or insomnia, or brain fog, and were assessed for those things individually. Several describe being offered antidepressants for what turned out to be a hormonal transition. Several describe being investigated for early dementia because they could not retrieve words.

The list of symptoms attributed to this transition is long and, to a woman experiencing three or four of them at once, faintly unbelievable: sleep disturbance, night sweats, hot flushes, low mood, anxiety, irritability, palpitations, joint and muscle pain, headaches or a change in migraine pattern, dry skin and eyes, thinning hair, urinary urgency, recurrent urinary tract infections, vaginal dryness and pain during sex, loss of libido, weight redistribution around the middle, and memory and concentration problems. Not everyone gets many of them. Nobody gets a warning.

The brain fog is the symptom women take most personally

Hot flushes get the headlines. Cognitive symptoms are what the accounts describe as genuinely frightening.

Women describe standing in a meeting unable to retrieve a colleague's name they have used for a decade. Reading a paragraph four times. Losing the thread mid-sentence. Several describe stepping back from promotions, or leaving jobs entirely, in the private conviction that they were failing and that it was becoming visible.

Two things come up repeatedly as helping. The first is simply knowing that this is a recognised feature of the transition rather than the beginning of decline, which several contributors describe as the single most reassuring thing anybody told them. The second is that it is, for most women, temporary; accounts commonly describe it lifting over a period of a year or two, whether or not they treated it.

What the current guidance actually says about HRT

The evidence and the guidance have moved considerably, and a great many women are working from an understanding formed in the early 2000s, when initial reporting of the Women's Health Initiative trial produced a collapse in prescribing and a generation of fear.

The current NICE guideline (NG23), substantially updated in 2024 and reviewed since, recommends hormone replacement therapy as the first-line treatment for vasomotor symptoms such as hot flushes and night sweats. It states plainly that HRT is unlikely to affect overall life expectancy. It sets out the individual risks in detail rather than as a blanket warning, including a small increase in breast cancer risk with combined HRT, and notes the benefit to bone density and fracture risk. It also introduced menopause-specific cognitive behavioural therapy as an option alongside HRT, or as an alternative for women who cannot take it or prefer not to, after an earlier draft that appeared to position CBT as a replacement drew significant criticism.

None of that means HRT is right for any particular woman. It means the conversation should be an individualised weighing of risks and benefits with a clinician, using the decision aids that now exist, rather than a flat refusal or a flat prescription. Women in these accounts who describe the best experiences are the ones who got that conversation. Women who describe the worst are, overwhelmingly, the ones who were told they were too young, or dismissed with "it's just your age".

The symptom that is easiest to treat and hardest to mention

Genitourinary symptoms of menopause — vaginal dryness, burning, pain during sex, urinary urgency, recurrent urinary tract infections — affect a very large proportion of women and, unlike hot flushes, do not resolve on their own. They tend to worsen over time if nothing is done.

They are also, according to these accounts, the symptoms women are least likely to raise. Contributors describe years of pain during sex without mentioning it, marriages quietly damaged by an avoidance neither partner would name, and repeated antibiotic courses for urinary infections without anyone connecting them to the underlying cause.

This category has specific local treatments distinct from systemic HRT, including options that current guidance addresses separately for women with a history of breast cancer. The recurring message from women who eventually raised it is that they wish they had done so years earlier, and that the clinician was entirely unsurprised.

Early and surgical menopause is a different experience

Menopause before forty, whether spontaneous, or following surgery, chemotherapy or radiotherapy, is described in these accounts as a categorically different event. It arrives without the gradual adjustment, often in the middle of a fertility timeline that was still open, and frequently alongside grief for children that will not now happen.

Women describe the particular isolation of it: support groups full of women twenty years older, friends who have no reference point, and a medical conversation about hormone replacement that has different considerations from the one had at fifty-two. Contributors consistently describe wanting to be told, at the point of diagnosis, that the emotional dimension was expected and legitimate rather than an overreaction.

Getting a useful appointment

The practical advice women give each other is consistent, and it is about preparation rather than persuasion.

Keep a written record of symptoms over several weeks, with dates and severity, rather than trying to recall them under pressure. Lead with the effect on your life — the meetings you cannot concentrate in, the sleep you are not getting — rather than a list of complaints, because impact is what gets acted on. Say what you have already read and what you want to discuss. Ask specifically about the decision aids the guideline now includes. And if you are told you are too young without any assessment, women describe asking to see somebody with a specific interest in menopause, which most practices can arrange.

Several contributors mention taking somebody with them, or writing the three things they would not leave without discussing on a card, having previously walked out of appointments having said none of them.

What women say they wish they had known

• That perimenopause starts years before periods stop, and that the symptoms of those years are not separate unrelated problems.
• That brain fog is a recognised feature, usually temporary, and not the start of decline.
• That the guidance on HRT has changed substantially since the early 2000s, and that the fear most women inherited is out of date.
• That vaginal and urinary symptoms do not improve on their own, have their own treatments, and are worth raising early.
• That sleep disruption drives a great deal of what feels like a mood disorder.
• That partners generally have no idea what is happening either, and that telling them helps.
• That being dismissed once is not the end of the process.

Reading the accounts in full

What a guideline cannot give you is what a Tuesday feels like at four in the morning with the sheets soaked and work in five hours. Our Women's Reproductive Health shelf gathers fifty first-person accounts in each volume, including Before the Change: Perimenopause Stories, The Change: Menopause Experience Stories and Early Change: Premature Menopause Stories. For treatment decisions specifically, HRT Horizons: Hormone Therapy Stories and Cooling the Flush: Non-Hormonal Menopause Relief Stories cover both routes, and The Conversation Nobody Starts: Menopause and Intimacy Stories covers the ground most women describe never discussing at all.

Each volume includes a section given over to the accounts where things did not resolve well, because a collection in which everyone sailed through would be no use to the woman reading it at four in the morning.

Sources and further reading

• NICE — Menopause: identification and management (NG23), including the information written for the public and the HRT discussion aids.
• Your GP, menopause specialist or gynaecologist, whose assessment of your individual risks and history overrides anything written here.

Healing Stories Network publishes anthologies of first-person patient testimony. This article describes what women report experiencing. It is companion reading and is not medical advice, diagnosis or treatment, and it is not a recommendation for or against any therapy. Read about who writes and checks our articles.